Opportunity Information: Apply for RFA RM 23 010
Apply for RFA RM 23 010
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: Molecular Transducers of Physical Activity Clinical Centers (U01 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310.
- This funding opportunity was created on 2023-03-22.
- Applicants must submit their applications by 2023-05-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2024.)
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Integration and Coordination Center for the Common Fund Data Ecosystem (U54 Clinical Trial Not Allowed)
Previous opportunity: IIJA Bureau of Land Management California Forest and Woodlands Resource Management
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA RM 23 010
Applicants also applied for:
Applicants who have applied for this opportunity (RFA RM 23 010) also looked into and applied for these:
| Funding Opportunity |
|---|
| Defining Mechanisms of HIV Induced Inflammation and Immune Activation During Suppressive Antiretroviral Therapy (ART) (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 018 Funding Number: RFA AI 23 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integration and Coordination Center for the Common Fund Data Ecosystem (U54 Clinical Trial Not Allowed) Apply for RFA RM 23 002 Funding Number: RFA RM 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) Apply for RFA RM 23 006 Funding Number: RFA RM 23 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional) Apply for RFA MH 23 260 Funding Number: RFA MH 23 260 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) Apply for RFA RM 23 007 Funding Number: RFA RM 23 007 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional) Apply for RFA NS 23 021 Funding Number: RFA NS 23 021 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) Apply for RFA RM 23 005 Funding Number: RFA RM 23 005 Agency: National Institutes of Health Category: Health Funding Amount: $900,000 |
| NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) Apply for PAR 23 132 Funding Number: PAR 23 132 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 022 Funding Number: RFA AI 23 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed) Apply for PAR 23 133 Funding Number: PAR 23 133 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional) Apply for RFA NS 23 022 Funding Number: RFA NS 23 022 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional) Apply for PAR 23 148 Funding Number: PAR 23 148 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Developing Measures to Advance Access and Quality in Global Mental Health Services (R34 Clinical Trial Not Allowed) Apply for RFA MH 23 300 Funding Number: RFA MH 23 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, Person-Centered Care to People with Long COVID (U18) Apply for RFA HS 23 012 Funding Number: RFA HS 23 012 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional) Apply for RFA NS 24 022 Funding Number: RFA NS 24 022 Agency: National Institutes of Health Category: Health Funding Amount: $1,200,000 |
| Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional) Apply for PAR 23 141 Funding Number: PAR 23 141 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) Apply for PAR 23 162 Funding Number: PAR 23 162 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed) Apply for RFA AR 24 003 Funding Number: RFA AR 24 003 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Developing Measures to Advance Quality in Mental Health Care Services (R01 Clinical Trial Not Allowed) Apply for RFA MH 23 265 Funding Number: RFA MH 23 265 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Fundamental Research to Understand the Mechanisms of Neurotropic Virus-mediated Disease (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 028 Funding Number: RFA AI 23 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 23 010", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.